Nano-enabled immunomodulation
Bibliographic record
Abstract
No abstract is available for this record. The assistant can identify its topic from the title, but cannot infer the study’s results.
Source: Not provided · Quality: missing
Research context
OpenAlex topics: RNA Interference and Gene Delivery · Advanced Drug Delivery Systems · Nanoparticle-Based Drug Delivery
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (6)
Show source-provided references
1. FDA approval brings first gene therapy to the United States. FDA https://www.fda.gov/news-events/press-announcements/fda-approval-brings-first-gene-therapy-united-states (2017).
2. FDA approves CAR-T cell therapy to treat adults with certain types of large B-cell lymphoma. FDA https://www.fda.gov/news-events/press-announcements/fda-approves-car-t-cell-therapy-treat-adults-certain-types-large-b-cell-lymphoma (2017).
3. U.S. FDA approves Kite’s Tecartus, the first and only CAR T treatment for relapsed or refractory mantle cell lymphoma. Business Wire https://www.businesswire.com/news/home/20200724005428/en/ (2020).
4. Duivenvoorden, R. et al. Nat. Rev. Cardiol. 16, 21–32 (2019).10.1038/s41569-018-0073-1 ↗
5. Sushnitha, M., Evangelopoulos, M. Tasciotti, E. & Taraballi, F. Front. Bioeng. Biotechnol. https://doi.org/10.3389/fbioe.2020.00627 (2020).10.3389/fbioe.2020.00627 ↗
6. Hubbell, J., Thomas, S. & Swartz, M. Nature 462, 449–460 (2009).10.1038/nature08604 ↗